Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,066 | -6,300 | -8,870 | N/A | -7,960 |
| Depreciation Amortization | 16 | 0 | 10 | N/A | 60 |
| Accounts receivable | 254 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 79 | N/A | N/A | N/A | N/A |
| Other Working Capital | 1,486 | -960 | -230 | N/A | 0 |
| Other Operating Activity | -1,423 | -70 | 440 | 0 | 2,040 |
| Operating Cash Flow | $-4,654 | $-7,330 | $-8,650 | $N/A | $-5,860 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -42 | -10 | -10 | N/A | 20 |
| Investing Cash Flow | $-42 | $-10 | $-10 | $N/A | $20 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,387 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 11,480 | 13,250 | 0 | 4,950 |
| Financing Cash Flow | $12,387 | $11,480 | $13,250 | $N/A | $4,950 |
| Exchange Rate Effect | -19 | -200 | 160 | N/A | 70 |
| Beginning Cash Position | 9,249 | 5,340 | 1,230 | N/A | 4,900 |
| End Cash Position | 16,921 | 9,280 | 5,980 | N/A | 4,090 |
| Net Cash Flow | $7,672 | $3,940 | $4,750 | $N/A | $-800 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,654 | -7,330 | -8,650 | N/A | -5,860 |
| Capital Expenditure | -45 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -4,699 | -7,330 | -8,650 | 0 | -5,860 |